Acalabrutinib May Offer a New Therapeutic Approach for Consolidation and Maintenance of Primary CNS Lymphoma with Expression of MYD88 and CD79B Gene Variants: A Case Report and Literature Review of Primary CNS Lymphoma in the BTKi Era.
Saved in:
| Title: | Acalabrutinib May Offer a New Therapeutic Approach for Consolidation and Maintenance of Primary CNS Lymphoma with Expression of MYD88 and CD79B Gene Variants: A Case Report and Literature Review of Primary CNS Lymphoma in the BTKi Era. |
|---|---|
| Authors: | Allison E; Liverpool Hospital, Liverpool, NSW 2170, Australia.; New South Wales Health Pathology, Liverpool, NSW 2170, Australia., Campbell A; Liverpool Hospital, Liverpool, NSW 2170, Australia.; New South Wales Health Pathology, Liverpool, NSW 2170, Australia.; Liverpool Campus, University of New South Wales, Liverpool, NSW 2170, Australia., Watson AM; Liverpool Hospital, Liverpool, NSW 2170, Australia.; New South Wales Health Pathology, Liverpool, NSW 2170, Australia.; Liverpool Campus, University of New South Wales, Liverpool, NSW 2170, Australia., Beaton B; Liverpool Hospital, Liverpool, NSW 2170, Australia.; New South Wales Health Pathology, Liverpool, NSW 2170, Australia.; Campbelltown Campus, Western Sydney University, Campbelltown, NSW 2560, Australia. |
| Source: | International journal of molecular sciences [Int J Mol Sci] 2025 Oct 29; Vol. 26 (21). Date of Electronic Publication: 2025 Oct 29. |
| Publication Type: | Journal Article; Case Reports; Review |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1422-0067 |
|---|---|
| DOI: | 10.3390/ijms262110521 |
